http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019535712-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00
filingDate 2017-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2019-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2019535712-A
titleOfInvention Crystal of GnRH receptor antagonist and method for producing the same
abstract A crystal of a GnRH receptor antagonist and a method for producing the same are provided. Specifically, 1- (4- (7- (2,6-difluorobenzyl) -3-((dimethylamino) methyl) -5- (6-methoxypyridazin-3-yl) -4,6-dicarbonyl -4,5,6,7-Tetrahydro-2H-pyrazolo [3,4-d] pyrimidin-2-yl) phenyl) -3-methoxyurea (compound of formula I) crystal I and process for preparation, pharmaceutical composition And its use in the manufacture of medicaments for the treatment of diseases associated with GnRH receptor antagonists.
priorityDate 2016-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016534989-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015532262-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108710621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431621538
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590756
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450151987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91755013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425064323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22018518
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458395052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36523
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261

Total number of triples: 51.